Envoy Medical, Inc. (COCHW) stock
COCHWNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as COCH
$0.03−0.00 (-15.49%)
Close on Oct 30, 2026Market cap $511.80MP/E –Yield –
Envoy Medical operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Envoy Medical's operating cash flow for the twelve months ending Jun 30, 2026 was -$21.53M. For fiscal 2025 it was -$18.20M. The highest annual figure on record is -$3.24M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$18.20M | – |
| FY2024 | Dec 31, 2024 | -$17.95M | – |
| FY2023 | Dec 31, 2023 | -$17.09M | – |
| FY2022 | Dec 31, 2022 | -$8.81M | – |
| FY2021 | Dec 31, 2021 | -$3.24M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$5.46M | – |
| Q1 FY2026 | Mar 31, 2026 | -$6.06M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.69M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.33M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.46M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.73M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.09M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.62M | -338.7% |
| Q2 FY2024 | Jun 30, 2024 | -$4.65M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.59M | – |
| Q4 FY2023 | Dec 31, 2023 | -$11.15M | – |
| Q3 FY2023 | Sep 30, 2023 | $1.10M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.03M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.01M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.38M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.25M | – |
| Q2 FY2022 | Jun 30, 2022 | -$400.16K | – |
| Q1 FY2022 | Mar 31, 2022 | -$772.74K | – |
| Q4 FY2021 | Dec 31, 2021 | -$885.17K | – |
| Q3 FY2021 | Sep 30, 2021 | -$701.35K | – |
| Q2 FY2021 | Jun 30, 2021 | -$405.32K | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.25M | – |